Publicação
CRISPR/Cas9-mediated knockout of miR-155 for Triple Negative Breast Cancer treatment
| Resumo: | Introduction Triple Negative Breast Cancer (TNBC) is the most aggressive breast cancer subtype. Lack of effective targeted therapies, significant genetic heterogeneity and poor response to conventional chemotherapies are the major reasons contributing to poor prognosis and high mortality rates. A subset of microRNAs (miRNAs) has been documented as oncogenic miRNAs (oncomiRs) because they have an important role in the regulation of tumour initiation and malignant progression. MiR-155 is among the most upregulated miRNAs in cancers and has been reported as associated with breast cancer progression and drug resistance. Methodology In this study, we demonstrate that miR-155 is significantly upregulated in a panel of TNBC cell lines. Therefore, we generated miR-155 knockdown cells using the CRISPR/Cas9 genome editing system. Streptococcus pyogenes CRISPR-associated nuclease Cas9 (SpCas9) vectors containing single-guide RNAs (sgRNAs) sequences targeting miR-155 gene were transfected into Hs578T cell line. Results and Conclusions We assessed the specificity of the designed sgRNAs through the cleavages at target loci and off-target effects by T7 Endonuclease I assays and DNA sequencing. In addition to demonstrating that CRISPR transient editing can reduce the expression of miR-155, we also confirmed the association between miR-155 and the transcription factor Forkhead box 3 (FOXO3), a negative regulator of Akt signalling pathway which is implicated in drug resistance. The present data suggests that CRISPR-based in vitro genome editing may provide a strategy for TNBC treatment. |
|---|---|
| Autores principais: | Sousa, Diana Andrade |
| Outros Autores: | Rodrigues, Joana Lúcia Lima Correia; Baltazar, Fátima; Rodrigues, L. R. |
| Ano: | 2020 |
| País: | Portugal |
| Tipo de documento: | póster em conferência |
| Tipo de acesso: | acesso restrito |
| Instituição associada: | Universidade do Minho |
| Idioma: | inglês |
| Origem: | RepositóriUM - Universidade do Minho |
Registos relacionados
category Targeting miR-155 in triple negative breast cancer via CRISPR/Cas9 delivery using peptide-engineered extracellular vesicles
por: Ferreira, Débora
Publicado em: (2025)
por: Ferreira, Débora
Publicado em: (2025)
category Potential of exosome-mediated delivery of CRISPR-Cas9 for microRNA-155 targeting in triple negative breast cancer
por: Gonçalves, Catarina Augusta Silva
Publicado em: (2024)
por: Gonçalves, Catarina Augusta Silva
Publicado em: (2024)
image In silico prediction and design of CRISPR sgRNAs targeting miR-155 for TNBC treatment
por: Sousa, Diana Andrade
Publicado em: (2020)
por: Sousa, Diana Andrade
Publicado em: (2020)
image Targeting oncogenic microRNAs in triple negative breast cancer using CRISPR/cas9 approach
por: Sousa, Diana Andrade
Publicado em: (2018)
por: Sousa, Diana Andrade
Publicado em: (2018)
category Targeting oncogenic microRNAs in triple negative breast cancer using a CRISPR/Cas9-based approach
por: Sousa, Diana Andrade
Publicado em: (2020)
por: Sousa, Diana Andrade
Publicado em: (2020)
article Matrix Gla protein repression by miR-155 promotes oncogenic signals in breast cancer MCF-7 cells
por: Tiago, Daniel
Publicado em: (2016)
por: Tiago, Daniel
Publicado em: (2016)
article CRISPR/Cas9‐mediated genome editing: from basic research to translational medicine
por: Jacinto, Filipe
Publicado em: (2020)
por: Jacinto, Filipe
Publicado em: (2020)
article In Vitro CRISPR/Cas9 Transfection and Gene-Editing Mediated by Multivalent Cationic LiposomeDNA Complexes
por: Sousa, Diana Andrade
Publicado em: (2022)
por: Sousa, Diana Andrade
Publicado em: (2022)
school CRISPR-Cas9 mutagenesis of the zebrafish foxm1
por: Carvalho, Ana Leonor Azevedo dos Santos
Publicado em: (2018)
por: Carvalho, Ana Leonor Azevedo dos Santos
Publicado em: (2018)
article Circulating miRNAs are associated with the systemic extent of atherosclerosis : novel observations for miR-27b and miR-146
por: Pereira da Silva, Tiago
Publicado em: (2021)
por: Pereira da Silva, Tiago
Publicado em: (2021)
school Development of cloning-free protocols for generation of gene knockouts using CRISPR-Cas9 technology in the model organisms Danio rerio Drosophila melanogaster and Mus Musculus
por: Craveiro, Catarina Filipe da Costa
Publicado em: (2017)
por: Craveiro, Catarina Filipe da Costa
Publicado em: (2017)
school Editing of the ADORA2A gene by CRISPR/Cas9
por: Costa, Raquel Lagoa Madruga da
Publicado em: (2021)
por: Costa, Raquel Lagoa Madruga da
Publicado em: (2021)
article Cellular delivery of CRISPR/Cas9 plasmid using multivalent cationic liposomes
por: Sousa, Diana Andrade
Publicado em: (2021)
por: Sousa, Diana Andrade
Publicado em: (2021)
article Overexpression of circulating MiR-30b-5p identifies advanced breast cancer
por: Estevão-Pereira, Helena
Publicado em: (2019)
por: Estevão-Pereira, Helena
Publicado em: (2019)
school Extracellular vesicle-mediated drug delivery in triple negative breast cancer
por: Gandarela, Leonor Batista
Publicado em: (2025)
por: Gandarela, Leonor Batista
Publicado em: (2025)
article MiR-146b negatively regulates migration and delays progression of T-cell acute lymphoblastic leukemia
por: Correia, Nádia
Publicado em: (2016)
por: Correia, Nádia
Publicado em: (2016)
groups miR-181a negatively regulates human γδ T cell differentiation into anti-tumor effectors
por: Gordino, Gisela
Publicado em: (2019)
por: Gordino, Gisela
Publicado em: (2019)
article Role of miR-21 in regenerating rat liver
por: Castro, R. E.
Publicado em: (2008)
por: Castro, R. E.
Publicado em: (2008)
article Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells
por: Almeida, Maria L.
Publicado em: (2012)
por: Almeida, Maria L.
Publicado em: (2012)
article CRISPR-Cas9: a powerful tool to efficiently engineer Saccharomyces cerevisiae
por: Costa, João Manuel Rainha
Publicado em: (2021)
por: Costa, João Manuel Rainha
Publicado em: (2021)
school Perfil de expressão dos microRNAs, miR-122 e miR-22, em doentes com hepatite crónica C
por: Neves, Sofia Maria Sentieiro
Publicado em: (2010)
por: Neves, Sofia Maria Sentieiro
Publicado em: (2010)
article Expression of tumor suppressors miR-195 and let-7a as potential biomarkers of invasive breast cancer
por: Marques, Marcia M.
Publicado em: (2018)
por: Marques, Marcia M.
Publicado em: (2018)
school Neuronal mitochondria and miR-124 crosstalk in Alzheimer’s disease
por: Rodrigues, Catarina Isabel Mougueira
Publicado em: (2019)
por: Rodrigues, Catarina Isabel Mougueira
Publicado em: (2019)
article Evidences for a new role of miR-214 in chondrogenesis
por: Roberto, Vania Palma
Publicado em: (2018)
por: Roberto, Vania Palma
Publicado em: (2018)
school Peptide-mediated targeted delivery system towards triple negative breast cancer treatment
por: Ferreira, Débora Carina Gonçalves Abreu
Publicado em: (2021)
por: Ferreira, Débora Carina Gonçalves Abreu
Publicado em: (2021)
category Peptide-mediated targeted delivery system towards triple negative breast cancer treatment
por: Ferreira, Débora
Publicado em: (2020)
por: Ferreira, Débora
Publicado em: (2020)
article CRISPR‑Cas9 engineered Saccharomyces cerevisiae for endolysin delivery to combat Listeria monocytogenes
por: Sáez Moreno, David
Publicado em: (2025)
por: Sáez Moreno, David
Publicado em: (2025)
category Optimizing CRISPR/Cas9 for high-expression genome loci in industrial yeast strains
por: Carvalho, Margarida
Publicado em: (2017)
por: Carvalho, Margarida
Publicado em: (2017)
article Cancer cells’ metabolism dynamics in renal cell carcinoma patients’ outcome: influence of GLUT-1-Related hsa-miR-144 and hsa-miR-186
por: Morais, Mariana
Publicado em: (2021)
por: Morais, Mariana
Publicado em: (2021)
school Exploring the neuroprotective role of miR-335 in experimental Parkinson's disease
por: Lúcio, Ana Cecília Moita do Rosário
Publicado em: (2021)
por: Lúcio, Ana Cecília Moita do Rosário
Publicado em: (2021)
school Drug-loaded magnetoliposomes for triple negative breast cancer therapy
por: Andrade, Raquel Gaudência Dias
Publicado em: (2026)
por: Andrade, Raquel Gaudência Dias
Publicado em: (2026)
category Non-viral delivery of CRISPR/Cas9 DNA for gene editing via multivalent cationic liposome system
por: Sousa, Diana Andrade
Publicado em: (2022)
por: Sousa, Diana Andrade
Publicado em: (2022)
category Engineered exosome-mediated delivery of RNAi therapeutics towards triple negative breast cancer therapy
por: Ferreira, Débora
Publicado em: (2021)
por: Ferreira, Débora
Publicado em: (2021)
school Correction of sickle-cell anemia using CRISPR-Cas9 system in hematopoietic stem cells
por: Draiblate, Beatriz Lopes
Publicado em: (2020)
por: Draiblate, Beatriz Lopes
Publicado em: (2020)
school Androgen receptor expression in triple-negative breast cancer
por: Rodrigues, Filipa Nascimento
Publicado em: (2014)
por: Rodrigues, Filipa Nascimento
Publicado em: (2014)
article miR-335 targets LRRK2 and mitigates inflammation in Parkinson’s disease
por: Oliveira, Sara
Publicado em: (2021)
por: Oliveira, Sara
Publicado em: (2021)
school Evaluation of miR-124 expression in the human hippocampus with focus on Alzheimer’s Disease
por: Cunha, Mariana de Castro Martins
Publicado em: (2019)
por: Cunha, Mariana de Castro Martins
Publicado em: (2019)
school MiR-21 role in colon cancer predisposition in PSC- IBD patients
por: Tibourtine, Sarah
Publicado em: (2023)
por: Tibourtine, Sarah
Publicado em: (2023)
article Potential of miR-21 to Predict Incomplete Response to Chemoradiotherapy in Rectal Adenocarcinoma
por: Ourô, Susana
Publicado em: (2020)
por: Ourô, Susana
Publicado em: (2020)
article Evidence for the conservation of miR-223 in zebrafish (Danio rerio): implications for function
por: Roberto, Vania Palma
Publicado em: (2015)
por: Roberto, Vania Palma
Publicado em: (2015)
Registos relacionados
-
category Targeting miR-155 in triple negative breast cancer via CRISPR/Cas9 delivery using peptide-engineered extracellular vesicles
por: Ferreira, Débora
Publicado em: (2025) -
category Potential of exosome-mediated delivery of CRISPR-Cas9 for microRNA-155 targeting in triple negative breast cancer
por: Gonçalves, Catarina Augusta Silva
Publicado em: (2024) -
image In silico prediction and design of CRISPR sgRNAs targeting miR-155 for TNBC treatment
por: Sousa, Diana Andrade
Publicado em: (2020) -
image Targeting oncogenic microRNAs in triple negative breast cancer using CRISPR/cas9 approach
por: Sousa, Diana Andrade
Publicado em: (2018) -
category Targeting oncogenic microRNAs in triple negative breast cancer using a CRISPR/Cas9-based approach
por: Sousa, Diana Andrade
Publicado em: (2020)